Disparities in Mortality Trends of Breast Cancer by Racial and Ethnic Status in the United States

Background and Aim: Breast cancer is the most commonly diagnosed malignancy for women and is a leading cause of mortality in women worldwide and in the United States. Recently, new interventions have been developed to improve its prognosis. The aim of this study was to assess the impact of new therapies on racial and ethnic groups in the United States for demographic-based disparities. We assessed the impact of these developments from 1999 to 2020 on age adjusted mortality rate (AAMR), mortality rate trend from 1999 to 2020, average annual percent change (AAPC), and temporal trends, by annual percent change (APC) in the United States for various demographic groups. Patients and Methods: We queried the CDC Wonder database to retrieve mortality rates by race and ethnic group from 1999 to 2020 with breast malignancy as a contributing cause of death. Results: Between 1999 to 2020, all racial groups presented a significant overall decline in mortality rates: AI/AN [AAPC, −1.6% (95% CI=−2.2% to −1.0%); p<0.01], AAPI [AAPC, −0.5% (95% CI=−1.00% to −0.1%); p<0.01], Black/African American [AAPC, −1.4% (95% CI=−1.6% to −1.2%); p<0.01], and the white population [AAPC, −1.7% (95% CI=−1.8% to −1.5%); p<0.01]. The Black/African American population had a significant lower rate of decline compared to the white population (p<0.01) and Hispanic/Latinx populations had a lower rate of decline compared to those who are non-Hispanic/Latinx (p<0.01). Conclusion: We found that Black/African American population had a significant lower rate of decline compared to the white population and Hispanic/Latinx populations had a lower rate of decline compared to those who are non-Hispanic/Latinx. These differences in mortality trend rates in breast cancer emphasize the need for targeted interventions and resources tailored to specific demographic needs.